Sanofi cuts 144 jobs in FrankfurtSanofi plans to cut 144 jobs in diabetes research at its largest plant in Frankfurt-Höchst as it is restructuring its research and development capacities, FAZ says on Friday (p21) (APMHE 63404).
China's Fosun considers buying Bayer's animal health businessChinese conglomerate Fosun international is considering bidding in a joint deal with a private equity firm for Bayer's animal-health business, said Handelsblatt (p27) and FAZ FAZ (p21) on Tuesday (APMHE 63357).
Versum shareholders agree to Merck KGaA dealMerck KGaA was able to convince shareholders of U.S. electronic materials maker Versum Materials to agree to a $53 per share takeover, FAZ said on Wednesday (p20).
Payer group criticises costs of new health laws in GermanyThe quick succession of cost-intensive new health laws in Germany is a challenge to statutory health insurance's €21 billion financial reserves, chair of umbrella payer group GKV-Spitzenverband Doris Pfeiffer told FAZ on Tuesday (p19).
Six hundred names on Monsanto's lobbying listingGerman group Bayer said on Twitter that 600 names have been collected since 2015 in France and Germany by public relations agencies for weed-killer maker Monsanto, mapping advocates and opponents for glyphosate and gene technology, SZ reported on Tuesday (p17).
Sanofi and Google deepening collaborationSanofi and Google have deepened their collaboration by building a joint innovation lab combining Sanofi's R&D data repository with Google's data analytics in the virtual space, FAZ reported on Wednesday (p22) (APMHE 63365).
Pfizer buys Array to keep pace in oncologyPfizer will buy cancer biotech Array Biopharma for $11 billion to keep pace in the oncology business, wrote Handelsblatt on Tuesday (p23).
Low trust in vaccination in Western EuropeTrust in vaccination is low in Western Europe, according to a global survey of public attitudes toward science and health by the British Wellcome Trust Foundation, said Die Welt on Thursday (p20).
TRY APM HEALTH EUROPE AND GET ACCESS TO THE FULL CONTENT
Interviews with KOLs/senior executives amongst the Regulators, Payers, Health, Medical & Pharmaceutical organisations
Events coverage with a unique focus on Market Access & sustainability of healthcare systems
6 European bureaus : Berlin, Brussels, London, Madrid, Milan & Paris
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.